Journal: Cancer discovery
Article Title: Successful Treatment of a Patient with Glioblastoma and a Germline POLE Mutation: Where Next?
PMID/MRN: 27807100
Publication Date: 2016-Nov-16
Abstract:
Hypermutation and elevated neoantigen count in glioblastoma occurred in a patient harboring a germline POLE mutation and are associated with a clinical and antitumor immune response to PD-1 blockade. Cancer Discov; 6(11); 1210-11. ©2016 AACR.See related article by Johanns et al., p. 1230.
©2016 American Association for Cancer Research.